UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...

Northwestern Medicine scientists have discovered new details about how the human genome produces instructions for creating ...

On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz with ...

Five years removed from the COVID-19 outbreak, scientists around the world are still studying its effects and, more importantly, ways those effects can be mitigated in the future.

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

Bird flu, Covid-19, and influenza are all respiratory infections spreading through respiratory droplets. While influenza ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities ...

You’ve certainly heard about antibodies, peptides, and even DNA as therapeutics, but what about RNA? In this review ... use mRNA technology to encode the spike protein of the SARS-CoV-2 virus. Once ...